Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Recombinant measles vector-based HIV-1 vaccine evaluated in primates

Sep. 29, 2011

Preclinical and first-in-human data presented on NDV-3 candidiasis vaccine

Sep. 29, 2011

Glycopyrrolate formulations show efficacy in randomized phase II trials in COPD

Sep. 28, 2011

Progenics discloses preclinical data on humanized MAbs targeting C. difficile toxins

Sep. 28, 2011

Phase I/II trial investigates polyepitope DNA vaccine in metastatic melanoma

Sep. 28, 2011

Taliglucerase alfa assessed in Gaucher's disease under French AUT program

Sep. 28, 2011

Basilea Pharmaceutica discloses more findings from first-in-human trial of BAL-30072

Sep. 28, 2011

Data disclosed from several trials assessing velaglucerase alfa in type 1 Gaucher's disease

Sep. 28, 2011

Synthesis and activity of novel IRAK-4 inhibitors described

Sep. 27, 2011

Study links gamma-enolase levels to febrile seizures in children

Sep. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...